Get the latest Science News and Discoveries
New tool may help prioritize high-risk infants for RSV immunization - EurekAlert
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, according to research published at the ATS 2024 International Conference.
None
Or read this on Eureka Alert